The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase

Autor:	Mori, Giorgia, Orena, Beatrice Silvia, Franch, Clara, Mitchenall, Lesley A., Godbole, Adwait Anand, Rodrigues, Liliana, Aguilar-Pérez, Clara, Zemanová, Júlia, Huszár, Stanislav, Forbak, Martin, Lane, Thomas R., Sabbah, Mohamad, Deboosere, Nathalie, Frita, Rosangela, Vandeputte, Alexandre, Hoffmann, Eik, Russo, Riccardo, Connell, Nancy, Veilleux, Courtney, Jha, Rajiv K., Kumar, Pradeep, Freundlich, Joel S., Brodin, Priscille, Aínsa, Jose Antonio, Nagaraja, Valakunja, Maxwell, Anthony, Mikušová, Katarína, Pasca, Maria Rosalia, Ekins, Sean
Zdroj:	In Tuberculosis September 2018 112:98-109
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect